Drug Profile
HIV vaccine - Profectus Biosciences
Alternative Names: HIV-1 vaccine - Profectus Biosciences; HIV-1-gag-vaccine; Recombinant vesicular stomatitis virus HIV-1 gag vaccine; rVSV HIV vaccine - Profectus Biosciences; rVSV HIV-1 gag vaccine; rVSVIN HIV-1 gag vaccine; rVSVN4CT1 HIVLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Profectus Biosciences
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 28 Apr 2018 No recent reports of development identified for phase-I development in HIV-infections in USA (IM, Injection)
- 28 Apr 2018 No recent reports of development identified for phase-I development in HIV-infections(Prevention, In volunteers) in USA (IM, Injection)
- 31 Oct 2014 Profectus in-licenses vaccine delivery technology from Yale University prior to October 2014